A meta-analysis encompassing 17 studies published in 2019 and another meta-analysis that included approximately 16,000 patients published in 2020 demonstrated that the frequency of KRAS mutations is higher in right-sided CRC [48,49]. This evidence concerns the gene KRAS and colorectal carcinoma.